A detailed history of Davidson Capital Management Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Davidson Capital Management Inc. holds 50 shares of MRNA stock, worth $6,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Holding current value
$6,108
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$85.37 - $115.44 $4,268 - $5,772
50 New
50 $5,000
Q3 2023

Oct 31, 2023

BUY
$96.41 - $126.61 $1,735 - $2,278
18 Added 64.29%
46 $4,000
Q2 2023

Aug 02, 2023

BUY
$118.5 - $160.53 $948 - $1,284
8 Added 40.0%
28 $3,000
Q1 2023

May 01, 2023

SELL
$135.66 - $197.02 $135 - $197
-1 Reduced 4.76%
20 $3,000
Q4 2022

Feb 07, 2023

BUY
$118.38 - $210.04 $473 - $840
4 Added 23.53%
21 $3,000
Q1 2022

May 17, 2022

BUY
$126.46 - $235.05 $2,149 - $3,995
17 New
17 $3,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $47.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Davidson Capital Management Inc. Portfolio

Follow Davidson Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Davidson Capital Management Inc. with notifications on news.